Alpha Teknova, Inc. (TKNO) income statement
TKNONasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/30131% above fair value
$7.88+0.23 (+3.01%)
Close on Nov 18, 2026Market cap $423.06MP/E –Yield –
Alpha Teknova, Inc. financial ratios
See a number that looks wrong?